Analysts have clear opinions on CRY.

There are 2 analysts on the Wall offering 12 month price targets for Cryolife in the last 3 months. The average price target is $31.00 with a high forecast of $32.00 and a low forecast of $30.00. The average price target represents a 5.12% increase from the last price of $29.49.
CryoLife, Inc. (CRY) is followed by 2 analysts on the street.

Michael Matson from Needham rates it a Buy with a target of $30.00.

Similarly, 2 months ago Jason Mills of Canaccord Genuity Reiterated a Buy with a target of $32.00.

The consensus on the street is Moderate Buy.

What does CryoLife, Inc.(CRY) do ?
CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the Medical Devices, and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products; On-X products; CardioGenesis cardiac laser therapy; PerClot; and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

CryoLife, Inc. (CRY) Insider Trades

Multiple company employees have indulged in significant insider trading. CryoLife, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

VP, GC, Holloway Jean F : S – Sale+OE(-$78,000) of CRY in the trading session of 2019-12-12.

VP, Clinical Research Capps Scott B : S – Sale+OE(-$179,108) of CRY in the trading session of 2019-11-26.

Dir McCall Ronald D : S – Sale(-$98,565) of CryoLife, Inc. in the trading session of 2019-11-19.

Looking for stocks just like CRY?

Based on Wall Street analyst research, several stocks are similar to CRY
They are:
– LMAT [Info can be found here: ]
– EW [Info can be found here: ]
– BAX [Info can be found here: ]